Magnetic resonance imaging of Alzheimer's disease

Prog Neuropsychopharmacol Biol Psychiatry. 1996 May;20(4):597-626. doi: 10.1016/0278-5846(96)00035-8.

Abstract

1. Although dementia is caused by a heterogeneous group of diseases and pathologic states, Alzheimer's disease is the largest cause, estimated to account for 50 to 75% of all dementias. 2. Unfortunately, confirmation of Alzheimer's disease (AD) requires postmortem histologic confirmation; clinical diagnosis prior to death remains one of exclusion. 3. A large number of structural and volumetric MRI studies have noted anatomic and structural changes accompanying AD, including variable degrees of general cortical atrophy. 4. A classic feature reported by many MRI studies is hippocampal and temporal lobe atrophy. 5. White matter hyperintensities on MRI are common, especially in late onset AD although their significance is still controversial. 6. This article reviews the contribution of magnetic resonance to imaging the neuropathologic changes of AD, discussing both advantages and limitations, and summarizing the major findings.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease / pathology*
  • Atrophy
  • Brain / pathology*
  • Humans
  • Magnetic Resonance Imaging